David W. Slack - 09 Jan 2023 Form 4 Insider Report for LISATA THERAPEUTICS, INC. (LSTA)

Role: President & CBO, Director
Signature: James Nisco, Attorney-in-fact for David Slack
Issuer symbol: LSTA
Transactions as of: 09 Jan 2023
Net transactions value: -$10,074
Form type: 4
Filing time: 11 Jan 2023, 15:10:05 UTC
Previous filing: 16 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LSTA	Common Stock	Award	$0	+24,000		$0.000000	24,000	09 Jan 2023	Direct	F1, F2
transaction	LSTA	Common Stock	Tax liability	$10,074	-3,358	-14%	$3.00	20,642	09 Jan 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LSTA	Stock Options (Right to Buy)	Award	$0	+12,000		$0.000000	12,000	09 Jan 2023	Common Stock	12,000	$3.00	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 24,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
F2	Includes 18,000 unvested restricted stock.
F3	Shares withheld as payment of a tax liability on vesting of restricted stock.
F4	One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.